Um, no, i am long in mnkd, an actual biotect trying to get an insulin inhaler approved. FDA has said no 2 times already, hoping 3rd time is the charm. Anyone who owns biotechs knows nothing is easy with FDA, haha...if it were we'd all be millionaires several times over lol@!
That is not a valid comparison. AFREZZA is an insulin product. An acutal medication. Insulin, yes, but it is a modification. The FUSE roll-on is merely a delivery method for existing medications. Although I would assume there must be some sort of compound with the FUSE method that helps the transdermal transfer